- BioPharm International-01-01-2015
- Volume 28
- Issue 1
Bioreactor Enhances Process Control
Sartorius Stedim Biotech’s BIOSTAT Cplus is a fermenter/bioreactor designed for the cultivation of microorganisms and cell cultures. The bioreactor is ideal for process development of vaccines, recombinant protein and monoclonal antibody production, biofuels, and secondary metabolites. Process strategy development can also be applied in batch, fed-batch, and continuous or perfusion operation, as well as scale-up and scale-down experiments. Culture vessels are available in operating volumes of 5, 10, 15, 20, and 30 liters.
A built-in sterilizable-in-place system is equipped with a DCU controller for upstream and downstream processes. The system allows up to four mass flow controllers and up to two scales or gravimetric feed controllers, and includes a pressure hold test to ensure control and safety. Each individual system can be adjusted for application-specific requirements, with automatic pressure control or integrated off-gas measurement options available.
Sartorius Stedim Biotech
Articles in this issue
almost 11 years ago
Great Expectations from New European Commissionalmost 11 years ago
Analyzing Protein Aggregation in Biopharmaceuticalsalmost 11 years ago
Raw Materials and the Development Cyclealmost 11 years ago
Fill/Finish Capacity Use for Biologicsalmost 11 years ago
Politics and Patients to Shape Pharma in 2015almost 11 years ago
Standards Organizations Updatealmost 11 years ago
Adopting the Product Lifecycle Approachalmost 11 years ago
Ligand-Binding Assays and the Determination of Biosimilarityalmost 11 years ago
Drug Breakthroughs, with Some Reservationsalmost 11 years ago
Technologies and Practices Must Evolve to Meet DemandNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.